vs
BANNER CORP（BANR）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是BANNER CORP的1.2倍（$207.3M vs $169.3M），BANNER CORP净利率更高（32.3% vs -62.0%，领先94.3%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 5.7%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 13.0%）
Banner Corp是总部位于美国华盛顿州沃拉沃拉的商业银行主体，旗下Banner银行的经营历史可追溯至1890年。业务覆盖商业地产、建筑、住宅、农业及消费贷款领域，还通过分布在华盛顿州、俄勒冈州、爱达荷州和加利福尼亚州的网点及贷款办事处提供社区银行服务。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
BANR vs RARE — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $169.3M | $207.3M |
| 净利润 | $54.7M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | — | -54.7% |
| 净利率 | 32.3% | -62.0% |
| 营收同比 | 5.7% | 25.9% |
| 净利润同比 | 21.2% | 3.5% |
| 每股收益（稀释后） | $1.60 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q1 26 | $169.3M | — | ||
| Q4 25 | $152.4M | $207.3M | ||
| Q3 25 | $150.0M | $159.9M | ||
| Q2 25 | $144.4M | $166.5M | ||
| Q1 25 | $141.1M | $139.3M | ||
| Q4 24 | $140.5M | $164.6M | ||
| Q3 24 | $135.7M | $139.5M | ||
| Q2 24 | $132.5M | $147.0M |
| Q1 26 | $54.7M | — | ||
| Q4 25 | — | $-128.6M | ||
| Q3 25 | $53.5M | $-180.4M | ||
| Q2 25 | $45.5M | $-115.0M | ||
| Q1 25 | $45.1M | $-151.1M | ||
| Q4 24 | — | $-133.2M | ||
| Q3 24 | $45.2M | $-133.5M | ||
| Q2 24 | $39.8M | $-131.6M |
| Q1 26 | — | — | ||
| Q4 25 | 10.0% | -54.7% | ||
| Q3 25 | 13.8% | -106.9% | ||
| Q2 25 | 12.3% | -64.8% | ||
| Q1 25 | 13.5% | -102.6% | ||
| Q4 24 | 14.3% | -74.3% | ||
| Q3 24 | 13.3% | -94.6% | ||
| Q2 24 | 13.0% | -79.1% |
| Q1 26 | 32.3% | — | ||
| Q4 25 | — | -62.0% | ||
| Q3 25 | 35.7% | -112.8% | ||
| Q2 25 | 31.5% | -69.0% | ||
| Q1 25 | 32.0% | -108.5% | ||
| Q4 24 | — | -80.9% | ||
| Q3 24 | 33.3% | -95.7% | ||
| Q2 24 | 30.0% | -89.5% |
| Q1 26 | $1.60 | — | ||
| Q4 25 | $1.49 | $-1.28 | ||
| Q3 25 | $1.54 | $-1.81 | ||
| Q2 25 | $1.31 | $-1.17 | ||
| Q1 25 | $1.30 | $-1.57 | ||
| Q4 24 | $1.34 | $-1.34 | ||
| Q3 24 | $1.30 | $-1.40 | ||
| Q2 24 | $1.15 | $-1.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.0B | $-80.0M |
| 总资产 | $16.3B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q1 26 | — | — | ||
| Q4 25 | $422.6M | $421.0M | ||
| Q3 25 | $672.9M | $202.5M | ||
| Q2 25 | $483.3M | $176.3M | ||
| Q1 25 | $441.9M | $127.1M | ||
| Q4 24 | $501.9M | $174.0M | ||
| Q3 24 | $478.8M | $150.6M | ||
| Q2 24 | $247.5M | $480.7M |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $-80.0M | ||
| Q3 25 | $1.9B | $9.2M | ||
| Q2 25 | $1.9B | $151.3M | ||
| Q1 25 | $1.8B | $144.2M | ||
| Q4 24 | $1.8B | $255.0M | ||
| Q3 24 | $1.8B | $346.8M | ||
| Q2 24 | $1.7B | $432.4M |
| Q1 26 | $16.3B | — | ||
| Q4 25 | $16.4B | $1.5B | ||
| Q3 25 | $16.6B | $1.2B | ||
| Q2 25 | $16.4B | $1.3B | ||
| Q1 25 | $16.2B | $1.3B | ||
| Q4 24 | $16.2B | $1.5B | ||
| Q3 24 | $16.2B | $1.5B | ||
| Q2 24 | $15.8B | $1.6B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
| Q1 26 | — | — | ||
| Q4 25 | $257.5M | $-99.8M | ||
| Q3 25 | $120.4M | $-91.4M | ||
| Q2 25 | $54.9M | $-108.3M | ||
| Q1 25 | $57.2M | $-166.5M | ||
| Q4 24 | $293.2M | $-79.3M | ||
| Q3 24 | $63.8M | $-67.0M | ||
| Q2 24 | $78.7M | $-77.0M |
| Q1 26 | — | — | ||
| Q4 25 | $247.9M | $-100.8M | ||
| Q3 25 | $118.7M | $-92.7M | ||
| Q2 25 | $52.1M | $-110.7M | ||
| Q1 25 | $55.6M | $-167.8M | ||
| Q4 24 | $279.4M | $-79.5M | ||
| Q3 24 | $60.4M | $-68.6M | ||
| Q2 24 | $74.3M | $-79.0M |
| Q1 26 | — | — | ||
| Q4 25 | 162.6% | -48.6% | ||
| Q3 25 | 79.1% | -58.0% | ||
| Q2 25 | 36.1% | -66.5% | ||
| Q1 25 | 39.4% | -120.5% | ||
| Q4 24 | 198.8% | -48.3% | ||
| Q3 24 | 44.5% | -49.2% | ||
| Q2 24 | 56.0% | -53.7% |
| Q1 26 | — | — | ||
| Q4 25 | 6.2% | 0.5% | ||
| Q3 25 | 1.2% | 0.8% | ||
| Q2 25 | 1.9% | 1.5% | ||
| Q1 25 | 1.2% | 1.0% | ||
| Q4 24 | 9.8% | 0.1% | ||
| Q3 24 | 2.5% | 1.2% | ||
| Q2 24 | 3.3% | 1.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.25× | — | ||
| Q2 25 | 1.21× | — | ||
| Q1 25 | 1.27× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.41× | — | ||
| Q2 24 | 1.98× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BANR
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
